Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo von Chaturvedi, A, Herbst, L, Pusch, S, Klett, L, Goparaju, R, Stichel, D, Kaulfuss, S, Panknin, O, Zimmermann, K, Toschi, L, Neuhaus, R, Haegebarth, A, Rehwinkel, H, Hess-Stumpp, H, Bauser, M, Bochtler, T, Struys, E A, Sharma, A, Bakkali, A, Geffers, R, Araujo-Cruz, M M, Thol, F, Gabdoulline, R, Ganser, A, Ho, A D, von Deimling, A, Rippe, K, Heuser, M, Krämer, A

Volltext

Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendr... von Feller, C., Felix, M., Weiss, T., Herold-Mende, C., Zhang, F., Kockmann, T., Sahm, F., Aebersold, R., von Deimling, A., Reuss, D. E.

Volltext

Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force von Soffietti, R., Baumert, B.G., Bello, L., Von Deimling, A., Duffau, H., Frénay, M., Grisold, W., Grant, R., Graus, F., Hoang-Xuan, K., Klein, M., Melin, B., Rees, J., Siegal, T., Smits, A., Stupp, R., Wick, W.

Volltext

Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation von Rettig, I, Koeneke, E, Trippel, F, Mueller, W C, Burhenne, J, Kopp-Schneider, A, Fabian, J, Schober, A, Fernekorn, U, von Deimling, A, Deubzer, H E, Milde, T, Witt, O, Oehme, I

Volltext

GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma von Livingstone, E., Zaremba, A., Horn, S., Ugurel, S., Casalini, B., Schlaak, M., Hassel, J.C., Herbst, R., Utikal, J.S., Weide, B., Gutzmer, R., Meier, F., Koelsche, C., Hadaschik, E., Sucker, A., Reis, H., Merkelbach‐Bruse, S., Siewert, M., Sahm, F., Deimling, A., Cosgarea, I., Zimmer, L., Schadendorf, D., Schilling, B., Griewank, K.G.

Volltext

Integrated molecular characterization of IDH‐mutant glioblastomas von Korshunov, A., Casalini, B., Chavez, L., Hielscher, T., Sill, M., Ryzhova, M., Sharma, T., Schrimpf, D., Stichel, D., Capper, D., Reuss, D. E., Sturm, D., Absalyamova, O., Golanov, A., Lambo, S., Bewerunge‐Hudler, M., Lichter, P., Herold‐Mende, C., Wick, W., Pfister, S. M., Kool, M., Jones, D. T. W., von Deimling, A., Sahm, F.

Volltext

The miR‐139‐5p regulates proliferation of supratentorial paediatric low‐grade gliomas by targeting the PI3K/AKT/mTORC1 signalling von Catanzaro, G., Besharat, Z. M., Miele, E., Chiacchiarini, M., Po, A., Carai, A., Marras, C. E., Antonelli, M., Badiali, M., Raso, A., Mascelli, S., Schrimpf, D., Stichel, D., Tartaglia, M., Capper, D., Deimling, A., Giangaspero, F., Mastronuzzi, A., Locatelli, F., Ferretti, E.

Volltext

Thrombus or tumor? A case report of a rare sarcoma entity: intimal sarcoma of the pulmonary arteries von Dörr, A., Flörcken, A., Bullinger, L., Capper, D., Deimling, A. Von, Kaul, D., Märdian, S., Starck, C., Horst, D., Dragomir, M.P., Schäfer, F.M., Jarosch, A.

Volltext

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells von Michaelis, M, Rothweiler, F, Barth, S, Cinatl, J, van Rikxoort, M, Löschmann, N, Voges, Y, Breitling, R, von Deimling, A, Rödel, F, Weber, K, Fehse, B, Mack, E, Stiewe, T, Doerr, H W, Speidel, D, Cinatl, J

Volltext

Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia von Balss, J, Thiede, C, Bochtler, T, Okun, J G, Saadati, M, Benner, A, Pusch, S, Ehninger, G, Schaich, M, Ho, A D, von Deimling, A, Krämer, A, Heilig, C E

Volltext

PROX1 is a predictor of survival for gliomas WHO grade II von Elsir, T, Qu, M, Berntsson, S G, Orrego, A, Olofsson, T, Lindström, M S, Nistér, M, von Deimling, A, Hartmann, C, Ribom, D, Smits, A

Volltext

Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q von Tews, B, Roerig, P, Hartmann, C, Hahn, M, Felsberg, J, Blaschke, B, Sabel, M, Kunitz, A, Toedt, G, Neben, K, Benner, A, von Deimling, A, Reifenberger, G, Lichter, P

Volltext

Downregulation of RUNX3 and TES by hypermethylation in glioblastoma von MUELLER, W, NUTT, C. L, EHRICH, M, RIEMENSCHNEIDER, M. J, VON DEIMLING, A, VAN DEN BOOM, D, LOUIS, D. N

Volltext

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment von Weiler, M, Pfenning, P-N, Thiepold, A-L, Blaes, J, Jestaedt, L, Gronych, J, Dittmann, L M, Berger, B, Jugold, M, Kosch, M, Combs, S E, von Deimling, A, Weller, M, Bendszus, M, Platten, M, Wick, W

Volltext

INI1 mutations in meningiomas at a potential hotspot in exon 9 von SCHMITZ, U, MUELLER, W, WEBER, M, SEVENET, N, DELATTRE, O, VON DEIMLING, A

Volltext

NDRG1 prognosticates the natural course of disease in WHO grade II glioma von Blaes, J., Weiler, M., Sahm, F., Hentschel, B., Osswald, M., Czabanka, M., Thomé, C. M., Schliesser, M. G., Pusch, S., Luger, S., Winkler, F., Radbruch, A., Jugold, M., Simon, M., Steinbach, J. P., Schackert, G., Tatagiba, M., Westphal, M., Tonn, J. C., Gramatzki, D., Pietsch, T., Hartmann, C., Glimm, H., Vajkoczy, P., von Deimling, A., Platten, M., Weller, M., Wick, W.

Volltext

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial von Wirsching, H.-G., Tabatabai, G., Roelcke, U., Hottinger, A.F., Jörger, F., Schmid, A., Plasswilm, L., Schrimpf, D., Mancao, C., Capper, D., Conen, K., Hundsberger, T., Caparrotti, F., von Moos, R., Riklin, C., Felsberg, J., Roth, P., Jones, D.T.W., Pfister, S., Rushing, E.J., Abrey, L., Reifenberger, G., Held, L., von Deimling, A., Ochsenbein, A., Weller, M.

Volltext

The age of adult pilocytic astrocytoma cells von Voronina, Natalia, Aichmüller, Christian, Kolb, Thorsten, Korshunov, Andrey, Ryzhova, Marina, Barnholtz-Sloan, Jill, Cioffi, Gino, Sill, Martin, von Deimling, Andreas, Pfister, Stefan M., Gronych, Jan, Jones, David T. W., Frisén, Jonas, Zapatka, Marc, Ernst, Aurélie

Volltext

Diagnostic value of immunohistochemistry for the detection of the BRAF mutation in primary lung adenocarcinoma Caucasian patients von Ilie, M., Long, E., Hofman, V., Dadone, B., Marquette, C.H., Mouroux, J., Vignaud, J.M., Begueret, H., Merlio, J.P., Capper, D., von Deimling, A., Emile, J.F., Hofman, P.

Volltext

Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles von van Landeghem, Frank K.H, Maier-Hauff, K, Jordan, A, Hoffmann, Karl-Titus, Gneveckow, U, Scholz, R, Thiesen, B, Brück, W, von Deimling, A

Volltext